
A rare fossa has arrived at Chester Zoo
Chester Zoo has just welcomed a rare fossa.But unlike many of its additions, this animal hasn't been born at the zoo. Seven-year-old fossa Zaza was brought to the UK from San Diego Zoo in the US as part of a special international breeding programme. The mission is to boost fossa numbers to stop them from going extinct.
Zaza has been matched with a female fossa at Chester Zoo called Shala and it's hoped the pair will go on to have pups. The animals tend to live alone, so the duo will stay apart most of the time, only coming together for breeding."Initially we plan to rotate the two of them separately around different parts of their habitat so they can smell each other," explained keeper Jack Cunningham. "They can see each other through a glass window and there's also a screen we can slide open between their dens which allows them to see each other, without being able to get to one another straight away."It's all part of our slow and gradual introduction process."Female fossa Shala, who arrived at Chester Zoo in 2018, successfully had a litter of pups with her previous mate, Isalo, who will be moving on from the zoo as part of the same breeding programme.
Why are their worries about fossa numbers?
The fossa is an animal which is native to Madagascar.Its existence is currently under threat, with fewer than 2,500 believed to still be in the wild. Deforestation has a big part to play in the fall in fossa numbers. "With the fossa listed as vulnerable to extinction by the International Union for the Conservation of Nature (IUCN), and its wild habitats in Madagascar under threat from rapid development, Zaza's move to Chester Zoo is an important part of the international effort to ensure this wonderful and unique species is safeguarded long into the future," said Mark Brayshaw, who is the head of mammals at Chester Zoo. As well as drastic changes to their environment, fossas also face risks from dogs and cats introduced to Madagascar as they risk catching catch diseases from them.
The fossa is the largest natural predator on Madagascar.They hunt for prey such as lemurs, which makes up about half of their diet, as well as other species like birds, lizards and mice. Although the animals have retractable claws like cats, they are most closely related to mongooses.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
an hour ago
- The Independent
Early symptoms of Alzheimer's can now be detected with a blood test
A new blood test for Alzheimer's disease has been found to accurately detect early symptoms of the illness, according to new research from the Mayo Clinic. The study, which was carried out on more than 500 people in an outpatient memory clinic, found the blood test was highly accurate, with 95 per cent sensitivity in picking up people with memory problems, and 82 per cent specificity in ruling out people without dementia. Dr Gregg Day, who led the study in the Alzheimer's and Dementia journal, said the test was as good as more invasive tests currently in use, and is much more convenient and cost-effective. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. The Blood Biomarker Challenge, supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research, aims to bring blood tests for dementia diagnosis to the NHS by 2029.


Daily Mail
3 hours ago
- Daily Mail
Statins slash death from terrifying 'hidden' condition that kills 48,000 a year by 40 per cent, new study finds
Taking statins can improve the chances of surviving 'hidden' killer sepsis by 40 per cent, a major new trial has found. Sepsis can occur when the body's immune system—which usually helps to fight infection—overreacts to an infection and attacks its own organs. It is notoriously difficult to spot as the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins are cholesterol-busting drugs that prevent heart attacks and strokes and are taken by around 5million adults in the UK. Experts have said they also have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The latest study compared survival rates of sepsis patients who were given statins, and those who didn't, during a hospital stay. It found the cholesterol-busting pills reduced risk of death for those with the life-threatening condition by 39 per cent. In the intensive care unit, 14.3 per cent of 6,000 sepsis patients who were given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. It also helped survival rates for those no longer in a critical condition—11 per cent of sepsis patients in this group given statins died compared to 19 per cent who were not. Meanwhile, those who were prescribed statins had a slightly longer stay in hospital than those who didn't—an average of 10 days compared to eight. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results strongly suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' The research team have called for larger trials to confirm their findings—which was based on a data from thousands of patients at a hospital in Israel over a decade. In response UK sepsis experts said that 'anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, added: 'It has been known for some time that the anti-inflammatory properties of statins confer a survival benefit on those who take them if they develop sepsis. 'Whilst previous studies have failed to show a similar survival benefit in treating people with sepsis with statins, this new study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' The study is the latest to find statins, one of the most commonly prescribed medications in the UK, could have other health benefits beyond controlling cholesterol. Earlier this year researchers found taking the pills, which cost mere pennies a tablet, could also slash dementia risk—even in patients who don't have high cholesterol. Sepsis, known as the 'silent killer', strikes with frightening speed and, for every hour of delay, a patient's chance of dying increases 8 per cent. If caught early enough, it can be easily treated with intravenous antibiotics and fluids, but these must be given as soon as sepsis is suspected. The early symptoms of sepsis can be easily confused with more mild conditions, meaning it can be difficult to diagnose. A high temperature, chills and shivering, a fast heartbeat and rapid breathing are also indicators. A patient can rapidly deteriorate if sepsis is missed early on, so quick diagnosis and treatment is vital–yet this rarely happens. In the early stages, sepsis can be mistaken for a chest infection, flu or upset stomach. It is most common and dangerous in older adults, pregnant women, children younger than one, people with chronic conditions or those who have weakened immune systems. The six potential signs of the deadly condition can be identified by the acronym 'SEPSIS'. Slurred speech or confusion, Extreme shivering or muscle pain, Passing no urine in a day, Severe breathlessness, and Skin that's mottled or discoloured. Anyone who develops any of these symptoms should seek medical help urgently—and ask doctors: 'Could this be sepsis?'


The Independent
3 hours ago
- The Independent
The big reason why we love Dippy the Dinosaur so much
Dippy – a complete cast of a diplodocus skeleton – is Britain's most famous dinosaur. It has resided at the Natural History Museum in London since 1905 and is now on show in Coventry where it is 'dinosaur-in-residence' at the Herbert Art Gallery & Museum. Dippy, the star attraction in the huge entrance hall of the Natural History Museum from 1979 to 2018, i s now on tour around the UK, with Coventry as its latest stop. It had previously been shown in Dorchester, Birmingham, Belfast, Glasgow, Newcastle, Cardiff, Rochdale, Norwich and London. So what is it that makes Dippy so popular? I got a sense of the dino's appeal in August 2021 when I gave a lecture under the Dippy skeleton in Norwich Cathedral. The lecture was about dinosaur feathers and colours. It highlighted new research that identified traces of pigment in the fossilised feathers of birds and dinosaurs. I wanted to highlight the enormous advances in the ways we can study dinosaurs that had taken place in just a century. Before arriving, I thought that Dippy would fill the cathedral – after all the skeleton is 26 metres long and it had filled the length of the gallery at the Natural History Museum. However, Dippy was dwarfed by the gothic cathedral's scale. In fact, the building is so large that five Dippys could line up, nose to tail, from the great west door to the high altar at the east end. This sense of awe is one of the key reasons to study palaeontology – to understand how such extraordinary animals ever existed. I asked the Norwich cathedral canon why they had agreed to host the dinosaur, and he gave three answers. First, the dinosaur would attract lots of visitors. Second, Dippy is from the Jurassic period, as are the rocks used to construct the cathedral. Finally, for visitors it shared with the cathedral a sense of awe because of its huge size. Far from being diminished by its temporary home, visitors still walked around and under Dippy sensing its grandeur. Dippy arrived in London in 1905 as part of a campaign for public education by the Scottish-American millionaire Andrew Carnegie (1835–1919). At the time, there was a debate in academic circles about the function of museums and how far professionals should go in seeking to educate the public. There was considerable reticence about going too far. Many professors felt that showing dinosaurs to the public would be unprofessional in instances where they moved from description of facts into the realm of speculation. They also did not want to risk ridicule by conveying unsupported information about the appearance and lifestyle of the great beasts. Finally, many professors simply did not see such populism as any part of their jobs. But, at that time, the American Museum of Natural History was well established in New York and its new president, Henry Fairfield Osborn (1857-1935) was distinctly a populist. He sponsored the palaeo artist Charles Knight (1874-1953), whose vivid colour paintings of dinosaurs were the glory of the museum and influential worldwide. Osborn was as hated by palaeontology professors as he was feted by the public. Carnegie pumped his steel dollars into many philanthropic works in his native Scotland and all over America, including the Museum of Natural History in Pittsburgh. When he heard that a new and complete skeleton of a diplodocus had been dug up in Wyoming, he bought it and brought it to his new museum. It was named as a new species, Diplodocus carnegiei. On a visit to Carnegie's Scottish residence, Skibo Castle, King Edward VII saw a sketch of the bones and Carnegie agreed to donate a complete cast of the skeleton to Britain's Natural History Museum. The skeleton was copied by first making rubber moulds of each bone in several parts, then filling the moulds with plaster to make casts and colouring the bones to make them look real. The 292 pieces were shipped to London in 36 crates and opened to the public in May 1905. Carnegie's original Dippy skeleton only went on show in Pittsburgh in 1907, after the new museum building had been constructed. Carnegie had got the royal bug and donated further complete Dippy casts to the great natural history museums in Berlin, Paris, Vienna, Bologna, St Petersburg, Madrid, Munich, Mexico City and La Plata in Argentina. Each of these nations, except France, had a king or tsar at the time. The skeletons went on show in all these locations, except Munich, and Dippy has been seen by many millions of people in the past 120 years. Dippy's appeal Dippy's appeal is manifold. It's huge – we like our dinosaurs big. It has been seen up close by more people around the world than any other dinosaur. It also opens the world of science to many people. Evolution, deep time, climate change, origins, extinction and biodiversity are all big themes that link biology, geology, physics, chemistry and mathematics. Also, since 1905, palaeontology has moved from being a largely speculative subject to the realms of testable science. Calculations of jaw functions and limb movements of dinosaurs can be tested and challenged. Hypotheses about physiology, reproduction, growth and colour can be based on evidence from microscopic study of bones and exceptionally preserved tissues, and these analyses can be repeated and refuted. Dippy has witnessed over a century of rapid change and its appeal is sure to continue for the next.